Back to search

Article

Covalent Inhibition of the Human Papillomavirus Type 16 E6 Protein Restores p53 and Suppresses HPV-Driven Tumorigenesis

2025-08-28

Abstract excerpt

<h4>SUMMARY</h4> High-risk human papillomavirus (HPV) infections are the etiology of approximately 5% of all cancers worldwide, including cervical, anal, and oropharyngeal malignancies. HPV E6 is a multifunctional oncoprotein that drives tumorigenesis and is best known for bridging the ubiquitin ligase E6AP (UBE3A) and p53 into a complex that leads to proteasome mediated destruction of p53. We developed small mol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
05044926-9337-53f6-8155-38a92d821ad1
DOI
10.1101/2025.08.24.671874
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Covalent Inhibition of the Human Papillomavirus Type 16 E6 Protein Restores p53 and Suppresses HPV-Driven TumorigenesisDOI 10.1101/2025.08.24.671874
Select a neighboring publication to make it the new centre.